Semenogelin I
| Semenogelin I | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||
| Symbols | SEMG1 ; MGC14719; SEMG; SGI | ||||||||||
| External IDs | Template:OMIM5 | ||||||||||
| |||||||||||
| RNA expression pattern | |||||||||||
| File:PBB GE SEMG1 206442 at tn.png | |||||||||||
| More reference expression data | |||||||||||
| Orthologs | |||||||||||
| Template:GNF Ortholog box | |||||||||||
| Species | Human | Mouse | |||||||||
| Entrez | n/a | n/a | |||||||||
| Ensembl | n/a | n/a | |||||||||
| UniProt | n/a | n/a | |||||||||
| RefSeq (mRNA) | n/a | n/a | |||||||||
| RefSeq (protein) | n/a | n/a | |||||||||
| Location (UCSC) | n/a | n/a | |||||||||
| PubMed search | n/a | n/a | |||||||||
Semenogelin I, also known as SEMG1, is a human gene.[1]
The protein encoded by this gene is the predominant protein in semen. The encoded secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes this protein into smaller peptides, with each possibly having a separate function. The proteolysis process breaks down the gel matrix and allows the spermatozoa to move more freely. Two transcript variants encoding different isoforms have been found for this gene.[1]
References
Further reading
- Robert M, Gagnon C (1999). "Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein". Cell. Mol. Life Sci. 55 (6–7): 944–60. PMID 10412373.
- Ulvsbäck M, Lazure C, Lilja H; et al. (1992). "Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20". J. Biol. Chem. 267 (25): 18080–4. PMID 1517240.
- Schneider K, Kausler W, Tripier D; et al. (1989). "[Isolation and structure determination of two peptides occurring in human seminal plasma]". Biol. Chem. Hoppe-Seyler. 370 (4): 353–6. PMID 2757795.
- Lilja H, Abrahamsson PA, Lundwall A (1989). "Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa". J. Biol. Chem. 264 (3): 1894–900. PMID 2912989.
- Li CH, Hammonds RG, Ramasharma K, Chung D (1985). "Human seminal alpha inhibins: isolation, characterization, and structure". Proc. Natl. Acad. Sci. U.S.A. 82 (12): 4041–4. PMID 3889920.
- Lilja H, Jeppsson JO (1985). "Amino acid sequence of the predominant basic protein in human seminal plasma". FEBS Lett. 182 (1): 181–4. PMID 3972122.
- Ramasharma K, Sairam MR, Seidah NG; et al. (1984). "Isolation, structure, and synthesis of a human seminal plasma peptide with inhibin-like activity". Science. 223 (4641): 1199–202. PMID 6422553.
- Lilja H, Laurell CB, Jeppsson JO (1984). "Characterization of the predominant basic protein in human seminal plasma, one cleavage product of the major seminal vesicle protein". Scand. J. Clin. Lab. Invest. 44 (5): 439–46. PMID 6484484.
- Seidah NG, Ramasharma K, Sairam MR, Chrétien M (1984). "Partial amino acid sequence of a human seminal plasma peptide with inhibin-like activity". FEBS Lett. 167 (1): 98–102. PMID 6698208.
- Khan Z, Smyth DG (1993). "Isolation and identification of N-terminally extended forms of 5-oxoprolylglutamylprolinamide (Glp-Glu-Pro-NH2), a thyrotropin-releasing-hormone (TRH)-like peptide present in human semen". Eur. J. Biochem. 212 (1): 35–40. PMID 8444163.
- Lundwall A (1996). "The structure of the semenogelin gene locus--nucleotide sequence of the intergenic and the flanking DNA". Eur. J. Biochem. 235 (3): 466–70. PMID 8654389.
- Malm J, Hellman J, Magnusson H; et al. (1996). "Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II". Eur. J. Biochem. 238 (1): 48–53. PMID 8665951.
- Bjartell A, Malm J, Moller C; et al. (1997). "Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry". J. Androl. 17 (1): 17–26. PMID 8833737.
- Robert M, Gibbs BF, Jacobson E, Gagnon C (1997). "Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.". Biochemistry. 36 (13): 3811–9. doi:10.1021/bi9626158. PMID 9092810.
- Peter A, Lilja H, Lundwall A, Malm J (1998). "Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase". Eur. J. Biochem. 252 (2): 216–21. PMID 9523691.
- Lövgren J, Airas K, Lilja H (1999). "Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors". Eur. J. Biochem. 262 (3): 781–9. PMID 10411640.
- Malm J, Hellman J, Hogg P, Lilja H (2000). "Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor". Prostate. 45 (2): 132–9. PMID 11027412.
- Deloukas P, Matthews LH, Ashurst J; et al. (2002). "The DNA sequence and comparative analysis of human chromosome 20". Nature. 414 (6866): 865–71. doi:10.1038/414865a. PMID 11780052.
- Brillard-Bourdet M, Réhault S, Juliano L; et al. (2002). "Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates". Eur. J. Biochem. 269 (1): 390–5. PMID 11784334.
 | This protein-related article is a stub. You can help Wikipedia by expanding it. |